SUMMARY The occurrence of e antigen in 44 patients with acute hepatitis B was studied in order to determine if e was related to the outcome of the illness. In 1 3-6 % of cases e was detected, and in none of these did the carrier state develop. The HBsAg carrier state developed in 4-6 % of the patients and in none of these was e antigen detected. Anti-e was detected in only three cases. Only in the very early acute phase of illness e was detected and the time serum samples were taken for the detection of e was considered to be very significant. The occurrence of e was not found to affect the duration of HBs antigenaemia in those patients who recovered completely.
In 1972 Magnius and Espmark identified a new antigen in the sera of some individuals who were carriers of hepatitis B antigen. It was suggested by them that 'e' might be an indicator of infectivity. Nielsen et al. (1974) subsequently suggested that e antigen might be of some prognostic value. They thought that when e was present in acute hepatitis, chronic liver disease might develop rather than full recovery. Norkrans et al. (1976) Results Table 1 gives the findings for e antigen. Although two patients are listed as having become carriers of HBsAg following acute hepatitis, this is not a certainty. The last available specimen from one of these patients was only three months after the onset of hepatitis and although this specimen was strongly positive (detectable by IEOP) for HBsAg, it is possible he could have eventually cleared. However, the other patient was still a carrier at seven months after the onset of hepatitis and at this point anti-e was first detected. No further specimens were received from this patient.
Anti-e was detected in only three cases of acute hepatitis B (Table 2 ). In one of the patients who had previously had detectable e antigen, anti-e was detected in the first HBsAg negative specimen three weeks after the onset ofjaundice. e Antigen had been detected in this patient only in the first HBsAg positive specimen just before the development of jaundice. Anti-e developed in the other patient, who recovered completely, only in the last HBsAg positive specimen.
As shown in Table 3 , it can be seen that in all six cases of acute hepatitis B, where e antigen was detected, it was seen within the first week following the onset ofjaundice. In one of these cases it was seen even before the appearance of jaundice. In five of these patients it was detected only in the first serum 925 Patricia E. Gibson and Kokila Ruparelia sample available. In the sixth patient it was detected in the first two serum samples, both of which were taken in the first week ofjaundice. Of the 44 patients studied, only in 15 was the first available serum sample taken within the first week of jaundice, and all six positive cases were in this group (40%). Table 4 indicates that the presence of e antigen in the acute phase of illness was not related to the duration of HBs antigenaemia in those patients who recovered completely. 
Discussion
Other studies (Eleftheriou et al., 1975; El Sheikh et al., 1975; Feinman et al., 1975; Nordenfelt et al., 1975; Vogten et al., 1976) 
